Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors.
about
Receptor tyrosine kinase-mediated angiogenesisPADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.Vascular Endothelial Growth Factor-B Induces a Distinct Electrophysiological Phenotype in Mouse Heart.Folic Acid Supplementation Delays Atherosclerotic Lesion Development by Modulating MCP1 and VEGF DNA Methylation Levels In Vivo and In Vitro(18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markersGrowth factors serum levels in coronary artery disease patients scheduled for bypass surgery: perioperative dynamics and comparisons with healthy volunteers.PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sproutingIntussusceptive angiogenesis: a biologically relevant form of angiogenesis.Angiogenesis-related microRNAs in colon cancer.Prolyl 4-hydroxylases, master regulators of the hypoxia response.In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure.A functional SNP in FLT1 increases risk of coronary artery disease in a Japanese population.Differential Regulation of Vascular Endothelial Growth Factors by Promoter-targeted shRNAs.PGC-1α: the missing ingredient for mesenchymal stem cell-mediated angiogenesis.Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-κB, and MAPK pathways.Modifications of microvascular EC surface modulate phototoxicity of a porphycene anti-ICAM-1 immunoconjugate; therapeutic implications.Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein.
P2860
Q27001612-B1C4E554-BB4F-472C-93E0-C9BA153AA04BQ30279209-852B5DEF-EE66-4B7C-9E62-92BE5F6A2AADQ33743164-B58197F1-FB54-4FEA-A35E-BFF1BB1B1E4CQ33755060-77760731-504F-42EB-8F91-161C497D1BDBQ34506127-A643BE4A-BC83-45B7-8DAB-9CADE062C0B7Q37101156-54F28AA2-5158-4A9F-85E8-231C9CE1DE5DQ37267378-0F848C79-86CE-40E9-93E6-117053B103E7Q38022128-B25C749C-C39D-4D37-9F91-D1B3B657C680Q38060849-1F50EBBB-CA22-4474-B127-83D71FA7F348Q38089239-93A8B223-D7CF-4723-B42B-C3D4F75ACA3FQ38682384-5C24DC36-18CA-4C6C-8619-3CEDABC5F2F4Q40962420-1FD44767-5AA5-418D-85FC-71EB65A75BE0Q41983561-F2FCF8DD-1C40-4F63-B2B4-0AC1D0A883EBQ42536326-EDE246AA-7B91-4A9B-BAF6-7CBE9B87BDE3Q42719164-8F59D703-2782-4B79-AE6C-71ACED8EDBEFQ42831090-A9279A0C-581B-489B-8412-9997510290C8Q48162548-B07D95F7-FD4C-4DEE-9942-C62B0A2F603F
P2860
Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@en
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@nl
type
label
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@en
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@nl
prefLabel
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@en
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@nl
P2860
P1476
Pro- and anti-angiogenic thera ...... ar endothelial growth factors.
@en
P2093
Suvi Jauhiainen
P2860
P356
10.1517/14712598.2012.641011
P407
P577
2011-11-25T00:00:00Z